Table 3.
CMP BMD-measurements and BMD-subgroup analysis man/woman.
| A | B | C | D | E | F | G | H | I | J | K | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Evolution-K® | |||||||||||
| ROI 1 | O.97 | - | 0.76 | -21.9 | 0.75 | -22.9 | 0.72 | -25.8 | -0.24 | -0.45 | p=0.101 |
| ROI 2 | 1.8 | - | 1.53 | -14.9 | 1.51 | -15.9 | 1.65 | -8.3 | -0.33 | -0.39 | p=0.932 |
| ROI 3 | 1.96 | - | 1.86 | -6.1 | 1.86 | -6 | 1.96 | 0 | -0.13 | -0.35 | p=0.242 |
| ROI 4 | 1.86 | - | 1.72 | -10.9 | 1.74 | -9.8 | 1.8 | -3.2 | -0.20 | -0.37 | p=0.443 |
| ROI 5 | 2.04 | - | 1.94 | -5.4 | 1.98 | -3.6 | 1.99 | -2.5 | -0.14 | -0.45 | p=0.332 |
| ROI 6 | 1.73 | - | 1.57 | -7.4 | 1.56 | -7.9 | 1.5 | -10.4 | -0.36 | -0.45 | p=0.887 |
| ROI 7 | 1.49 | - | 1.04 | -27.5 | 1.0 | -30.3 | 0.91 | -40.3 | -0.69 | -0.71 | p=0.755 |
| Adaptiva® | |||||||||||
| ROI 1 | 0.88 | - | 0.79 | -10.8 | - | - | 0.95 | 8 | 0.29 | -0.15 | p=0.002 |
| ROI 2 | 1.69 | - | 1.57 | -6.8 | - | - | 1.89 | 11.8 | 0.50 | -0.08 | p=0.003 |
| ROI 3 | 1.96 | - | 1.87 | -4.9 | - | - | 2.24 | 14.3 | 0.50 | 0.09 | p=0.003 |
| ROI 4 | 1.92 | - | 1.86 | -5.1 | - | - | 1.98 | 3.1 | 0.21 | -0.05 | p=0.042 |
| ROI 5 | 1.93 | - | 1.87 | -3.1 | - | - | 2.18 | 13 | 0.41 | 0.12 | p=0.020 |
| ROI 6 | 1.61 | - | 1.48 | -8.0 | - | - | 1.50 | -6.8 | 0.09 | -0.36 | p=0.003 |
| ROI 7 | 1.51 | - | 1.15 | -23.7 | - | - | 1.06 | -29.8 | -0.32 | -0.61 | p=0.010 |
A: BMD 10 d post-OP [g/cm2]. B: Difference based on the measurement 10 d post-OP [%]. C: BMD 4 y (Evolution-K®) / 2 y (Adaptiva®) post-OP [g/cm2]. D: Difference based on the measurement 10 d post-OP [%]. E: BMD 5 y post-OP [g/cm2]. F: Dif-ference based on the measurement 10 d post-OP [%]. G: BMD 16 y (Evolution-K®) /13 y (Adaptiva®) post-OP [g/cm2]. H: Dif-ference based on the measurement 10 d post-OP [%]. I: Mean subgroup “man” [g/cm2]. J: Mean subgroup „woman“ [g/cm2]. K: Mann-Whitney-U-test (t-Test).